Prof. Dr. Dr. Ingolf Cascorbi

Institut für Experimentelle und Klinische Pharmakologie

Direktor

Telefon Kiel: 0431 500-30400 | Fax: -30404

Publikationen

Education and Training

1978-1985	Study of biochemistry, Free University of Berlin
1986-1992	Study of medicine, Free University of Berlin
1989	PhD (Dr. rer. nat.), Free University of Berlin, Germany
1998	Board certification: clinical pharmacology
1999	MD (Dr. med.), Humboldt University of Berlin, Germany
2000	Habilitation, Humboldt University of Berlin, Germany

Positions and Employment

1985-1992	Research Associate, Institute of Biochemistry and Molecular Biology, Free University Berlin, Germany
1993-1994	Medical Residency, Institute of Clinical Pharmacology, University Medical Center Benjamin Franklin, Free University of Berlin
1994-1999	Research Associate, Institute of Clinical Pharmacology, Charité, HU Berlin, Germany
2000-2004	Professor of Pharmacology and Toxicology, Ernst Moritz Arndt University Greifswald, Germany
2004-present	Professor and Chair of Pharmacology, Christian Albrechts University Kiel, Germany

Research Interests

Research in pharmacogenomics and epigenomics of drug metabolizing enzymes and drug transporters, molecular background of pharmacotherapy resistance and adverse drug reactions. Major funding by BMBF, EU, DFG, industrial research co-operations

Further Tasks

President International Union of Basic and Clinical Pharmacology (IUPHAR) 2018-2022 Chairman German Society for Clinical Pharmacology and Therapeutics (DGKliPhar) 2019-2021 Board Member: European Society for Pharmacogenomics and Theranostics (ESPT);
Memberships: Commission on Genetic Testing, Robert-Koch-Institute; Drug Commission of the German Medical Association (AKdÄ)

Editorial Boards

Basic & Clinical Pharmacology & Toxicology; British Journal of Clinical Pharmacology; Clinical Pharmacology and Therapeutics (Associate Editor); Pharmacogenetics & Genomics; Pharmacogenomics; Therapeutic Drug Monitoring; Deutsches Ärzteblatt International